Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)
INR 56.84
(0.0%)
INR 56.84
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 113.02 Million INR | 8.55% |
| 2022 | 104.12 Million INR | -46.73% |
| 2021 | 195.44 Million INR | 93.55% |
| 2020 | 100.98 Million INR | 1.93% |
| 2019 | 99.07 Million INR | -27.85% |
| 2018 | 137.32 Million INR | 21.85% |
| 2017 | 112.7 Million INR | -13.17% |
| 2016 | 129.78 Million INR | 332.68% |
| 2015 | 29.99 Million INR | -5.52% |
| 2014 | 31.74 Million INR | -6.3% |
| 2013 | 33.88 Million INR | -1.95% |
| 2012 | 34.55 Million INR | 20.31% |
| 2011 | 28.72 Million INR | 27.14% |
| 2010 | 22.59 Million INR | 77.02% |
| 2009 | 12.76 Million INR | -53.87% |
| 2008 | 27.66 Million INR | 47.98% |
| 2007 | 18.69 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 27.13 Million INR | -7.97% |
| 2023 FY | 113.02 Million INR | 8.55% |
| 2023 Q1 | 29.49 Million INR | 664.27% |
| 2023 Q3 | 31.36 Million INR | 17.87% |
| 2023 Q2 | 26.6 Million INR | -9.79% |
| 2023 Q4 | 36.04 Million INR | 14.93% |
| 2022 FY | 104.12 Million INR | -46.73% |
| 2022 Q4 | 3.85 Million INR | -89.97% |
| 2022 Q1 | 6 Million INR | -86.74% |
| 2022 Q2 | 55.77 Million INR | 828.41% |
| 2022 Q3 | 38.48 Million INR | -31.0% |
| 2021 Q2 | 53.24 Million INR | 15.36% |
| 2021 Q1 | 46.15 Million INR | 70.61% |
| 2021 Q3 | 50.74 Million INR | -4.68% |
| 2021 Q4 | 45.3 Million INR | -10.73% |
| 2021 FY | 195.44 Million INR | 93.55% |
| 2020 FY | 100.98 Million INR | 1.93% |
| 2020 Q1 | 26.18 Million INR | 188.79% |
| 2020 Q4 | 27.05 Million INR | -11.65% |
| 2020 Q3 | 30.62 Million INR | 115.36% |
| 2020 Q2 | 14.21 Million INR | -45.71% |
| 2019 Q3 | 38.25 Million INR | 54.4% |
| 2019 Q4 | 9.06 Million INR | -76.3% |
| 2019 Q1 | 26.97 Million INR | -46.32% |
| 2019 FY | 99.07 Million INR | -27.85% |
| 2019 Q2 | 24.77 Million INR | -8.13% |
| 2018 Q2 | 36.24 Million INR | 80.1% |
| 2018 Q1 | 20.12 Million INR | -49.93% |
| 2018 Q3 | 30.71 Million INR | -15.24% |
| 2018 FY | 137.32 Million INR | 21.85% |
| 2018 Q4 | 50.24 Million INR | 63.55% |
| 2017 FY | 112.7 Million INR | -13.17% |
| 2017 Q4 | 40.18 Million INR | 36.77% |
| 2017 Q3 | 29.38 Million INR | 14.81% |
| 2017 Q2 | 25.59 Million INR | 3.72% |
| 2017 Q1 | 24.67 Million INR | -43.77% |
| 2016 Q2 | 30.26 Million INR | 16.93% |
| 2016 Q3 | 30.19 Million INR | -0.26% |
| 2016 FY | 129.78 Million INR | 332.68% |
| 2016 Q4 | 43.88 Million INR | 45.35% |
| 2016 Q1 | 25.88 Million INR | 110.41% |
| 2015 Q4 | 12.3 Million INR | 397.9% |
| 2015 FY | 29.99 Million INR | -5.52% |
| 2015 Q3 | 2.47 Million INR | -59.28% |
| 2015 Q2 | 6.06 Million INR | -52.35% |
| 2015 Q1 | 12.73 Million INR | 276.91% |
| 2014 Q4 | -7.19 Million INR | -176.52% |
| 2014 FY | 31.74 Million INR | -6.3% |
| 2014 Q1 | 14.31 Million INR | 212.59% |
| 2014 Q2 | 15.22 Million INR | 6.36% |
| 2014 Q3 | 9.4 Million INR | -38.21% |
| 2013 Q4 | -12.71 Million INR | -191.98% |
| 2013 FY | 33.88 Million INR | -1.95% |
| 2013 Q1 | 6.9 Million INR | 231.54% |
| 2013 Q2 | 25.87 Million INR | 275.0% |
| 2013 Q3 | 13.82 Million INR | -46.58% |
| 2012 Q3 | 16.49 Million INR | 28.93% |
| 2012 Q1 | 10.51 Million INR | 248.67% |
| 2012 FY | 34.55 Million INR | 20.31% |
| 2012 Q2 | 12.79 Million INR | 21.65% |
| 2012 Q4 | -5.24 Million INR | -131.8% |
| 2011 Q3 | 9.06 Million INR | 0.0% |
| 2011 Q4 | 3.01 Million INR | -66.72% |
| 2011 FY | 28.72 Million INR | 27.14% |
| 2010 FY | 22.59 Million INR | 77.02% |
| 2009 FY | 12.76 Million INR | -53.87% |
| 2008 Q4 | 7.2 Million INR | 0.0% |
| 2008 FY | 27.66 Million INR | 47.98% |
| 2007 FY | 18.69 Million INR | 0.0% |
| 2007 Q4 | 6.15 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | 94.355% |
| Ind-Swift Limited | 2.17 Billion INR | 94.797% |
| Bajaj HealthCare Limited | 1.47 Billion INR | 92.32% |
| Sakar Healthcare Limited | 699.58 Million INR | 83.843% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 99.897% |
| Innova Captab Limited | 3.46 Billion INR | 96.737% |
| Divi's Laboratories Limited | 32.44 Billion INR | 99.652% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 98.184% |
| Morepen Laboratories Limited | 6.16 Billion INR | 98.165% |
| Mankind Pharma Limited | 42.19 Billion INR | 99.732% |
| Sequent Scientific Limited | 2.97 Billion INR | 96.205% |
| Wanbury Limited | 1.73 Billion INR | 93.469% |
| Laurus Labs Limited | 15.44 Billion INR | 99.268% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 97.657% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 99.091% |
| Alembic Limited | 1 Billion INR | 88.698% |
| Hikal Limited | 5.95 Billion INR | 98.103% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 99.578% |
| Neuland Laboratories Limited | 8.24 Billion INR | 98.63% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 99.259% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 99.837% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 97.605% |
| Themis Medicare Limited | 2.42 Billion INR | 95.329% |
| RPG Life Sciences Limited | 2.48 Billion INR | 95.448% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 99.91% |
| Lupin Limited | 125.09 Billion INR | 99.91% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | 94.602% |
| Wockhardt Limited | 7.72 Billion INR | 98.536% |
| Vaishali Pharma Limited | 90.32 Million INR | -25.139% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 98.062% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | 82.68% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 99.425% |
| FDC Limited | 6.58 Billion INR | 98.284% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 99.931% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | 81.784% |
| Eris Lifesciences Limited | 10.42 Billion INR | 98.916% |
| Venus Remedies Limited | 2.18 Billion INR | 94.821% |
| ZIM Laboratories Limited | 1.26 Billion INR | 91.085% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 96.941% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | 78.639% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 98.772% |
| Shilpa Medicare Limited | 3.56 Billion INR | 96.827% |
| Albert David Limited | 1.4 Billion INR | 91.973% |
| Ajanta Pharma Limited | 21.06 Billion INR | 99.463% |
| Hester Biosciences Limited | 1.27 Billion INR | 91.126% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 97.259% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 106.826% |
| Gufic Biosciences Limited | 4.07 Billion INR | 97.225% |
| Windlas Biotech Limited | 1.33 Billion INR | 91.557% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 98.045% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | 83.647% |
| Granules India Limited | 16.79 Billion INR | 99.327% |
| Aarti Drugs Limited | 8.31 Billion INR | 98.641% |
| Bal Pharma Limited | 770.19 Million INR | 85.325% |
| Alkem Laboratories Limited | 52.29 Billion INR | 99.784% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 99.956% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | 94.01% |
| Medicamen Biotech Limited | 495.49 Million INR | 77.189% |
| Unichem Laboratories Limited | 4.86 Billion INR | 97.677% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | 75.002% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -800.988% |
| Valiant Laboratories Limited | 138.02 Million INR | 18.112% |
| Orchid Pharma Limited | 2.32 Billion INR | 95.129% |
| Medico Remedies Limited | 262.14 Million INR | 56.883% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 97.265% |
| Ipca Laboratories Limited | 48.58 Billion INR | 99.767% |
| Brooks Laboratories Limited | 65.62 Million INR | -72.248% |
| Syncom Formulations (India) Limited | 559.5 Million INR | 79.798% |
| Piramal Enterprises Limited | 8.04 Billion INR | 98.595% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 99.758% |
| NATCO Pharma Limited | 25.73 Billion INR | 99.561% |
| Suven Life Sciences Limited | -200.79 Million INR | 156.29% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 203.938% |
| Strides Pharma Science Limited | 14.38 Billion INR | 99.214% |
| Indoco Remedies Limited | 8.04 Billion INR | 98.595% |
| Alpa Laboratories Limited | 188.89 Million INR | 40.163% |
| Lasa Supergenerics Limited | 121.02 Million INR | 6.611% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | 71.097% |